These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30975469)

  • 1. Reducing NETO2 expression prevents human nasopharyngeal carcinoma (NPC) progression by suppressing metastasis and inducing apoptosis.
    He AR; Zhu Q; Gao S
    Biochem Biophys Res Commun; 2019 May; 513(2):494-501. PubMed ID: 30975469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
    Qian W; Ren Z; Lu X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
    Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CASC15 promotes nasopharyngeal carcinoma cell proliferation and metastasis by downregulating miR-101-3p.
    Xue MY; Cao HX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8897-8904. PubMed ID: 31696476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
    Zhang Y; Zhang W
    Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. URG4-silencing suppresses cell proliferation in nasopharyngeal carcinoma through induction of apoptosis.
    Luo XY; Yan B; Cai CF; Chen AM; Zhou M
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1717-1725. PubMed ID: 29630117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
    Zhou D; Ye C; Pan Z; Deng Y
    Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma.
    Liu J; Chen W; Chen Z; Wen J; Yu H; Wang F; Wu L; He X
    Biomed Pharmacother; 2017 Sep; 93():869-878. PubMed ID: 28724212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
    Li YQ; Ren XY; He QM; Xu YF; Tang XR; Sun Y; Zeng MS; Kang TB; Liu N; Ma J
    Cell Death Dis; 2015 Jan; 6(1):e1618. PubMed ID: 25611392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of TMPRSS3, a Transmembrane Serine Protease, Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.
    Wang JY; Jin X; Li XF
    Oncol Res; 2018 Jan; 26(1):95-101. PubMed ID: 28409556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN.
    Han JB; Huang ML; Li F; Yang R; Chen SM; Tao ZZ
    Cancer Biother Radiopharm; 2020 Oct; 35(8):615-625. PubMed ID: 32101017
    [No Abstract]   [Full Text] [Related]  

  • 17. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
    Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition.
    Ke Z; Xie F; Zheng C; Chen D
    J Cell Physiol; 2019 Feb; 234(2):1699-1706. PubMed ID: 30070690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.
    Chen S; Youhong T; Tan Y; He Y; Ban Y; Cai J; Li X; Xiong W; Zeng Z; Li G; Yi M; Liu W; Xiang B
    Carcinogenesis; 2020 Jul; 41(6):723-733. PubMed ID: 31665243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
    Zhuang K; Wu Q; Jin CS; Yuan HJ; Cheng JZ
    Cancer Biomark; 2016; 16(2):291-300. PubMed ID: 26756620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.